Summit Therapeutics Inc

NASDAQ:SMMT   1:00:00 PM EDT
24.55
+1.93 (+8.53%)
4:59:29 PM EDT: $24.40 -0.15 (-0.61%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Summit Therapeutics Inc Stock, NASDAQ:SMMT

601 Brickell Key Drive, Suite 1000, Miami, Florida 33131
United States of America
Phone: +1.305.203.2034
Number of Employees: 159

Description

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.